Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Aiuti

Showing results (11-20 of 268) with videos related to

Pageof 27
Sort By:
Blood|March 2, 2023
Towards improved yet regulated gene therapy for X-CGDAnna Kajaste-Rudnitski, Alessandro Aiuti
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 5, 2020
New perspectives in gene therapy for inherited disordersMaria Pia Cicalese, Alessandro Aiuti
Current Opinion in Allergy and Clinical Immunology|September 26, 2009
New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapyAisha V Sauer, Alessandro Aiuti
Human Gene Therapy|April 11, 2015
Clinical applications of gene therapy for primary immunodeficienciesMaria Pia Cicalese, Alessandro Aiuti
Human Gene Therapy|August 18, 2016
The Role of Conditioning in Hematopoietic Stem-Cell Gene TherapyMaria Ester Bernardo, Alessandro Aiuti
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 19, 2012
Retroviral integrations in gene therapy trialsLuca Biasco, Cristina Baricordi, Alessandro Aiuti
Nature Reviews. Genetics|March 11, 2025
Challenges and solutions to the sustainability of gene and cell therapiesCeleste Scotti, Alessandro Aiuti, Luigi Naldini
Nature Medicine|August 15, 2022
Ensuring a future for gene therapy for rare diseasesAlessandro Aiuti, Francesca Pasinelli, Luigi Naldini
Current Opinion in Allergy and Clinical Immunology|October 23, 2010
Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiencyFrancesca Ferrua, Immacolata Brigida, Alessandro Aiuti
Nature Reviews. Genetics|December 11, 2020
Gene therapy using haematopoietic stem and progenitor cellsGiuliana Ferrari, Adrian J Thrasher, Alessandro Aiuti
Pageof 27

Showing results (11-20 of 268) with videos related to

Sort By:
Pageof 27
Blood|March 2, 2023
Towards improved yet regulated gene therapy for X-CGDAnna Kajaste-Rudnitski, Alessandro Aiuti
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 5, 2020
New perspectives in gene therapy for inherited disordersMaria Pia Cicalese, Alessandro Aiuti
Current Opinion in Allergy and Clinical Immunology|September 26, 2009
New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapyAisha V Sauer, Alessandro Aiuti
Human Gene Therapy|April 11, 2015
Clinical applications of gene therapy for primary immunodeficienciesMaria Pia Cicalese, Alessandro Aiuti
Human Gene Therapy|August 18, 2016
The Role of Conditioning in Hematopoietic Stem-Cell Gene TherapyMaria Ester Bernardo, Alessandro Aiuti
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 19, 2012
Retroviral integrations in gene therapy trialsLuca Biasco, Cristina Baricordi, Alessandro Aiuti
Nature Reviews. Genetics|March 11, 2025
Challenges and solutions to the sustainability of gene and cell therapiesCeleste Scotti, Alessandro Aiuti, Luigi Naldini
Nature Medicine|August 15, 2022
Ensuring a future for gene therapy for rare diseasesAlessandro Aiuti, Francesca Pasinelli, Luigi Naldini
Current Opinion in Allergy and Clinical Immunology|October 23, 2010
Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiencyFrancesca Ferrua, Immacolata Brigida, Alessandro Aiuti
Nature Reviews. Genetics|December 11, 2020
Gene therapy using haematopoietic stem and progenitor cellsGiuliana Ferrari, Adrian J Thrasher, Alessandro Aiuti
Pageof 27